Assignee
WELLSTAT THERAPEUTICS CORP
US·51 granted patents·18 pending applications·853 citations·filing 1995–2022
Top patents by PatentIndex Score
69 records- 0198US6924314B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Aug 2, 2005·84 cites·13 claims
- 0297US7101910B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2002·Granted Sep 5, 2006·66 cites·10 claims
- 0397US7041659B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted May 9, 2006·66 cites·3 claims
- 0497US7012071B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Mar 14, 2006·65 cites·6 claims
- 0597US6946491B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Sep 20, 2005·70 cites·19 claims
- 0697US6916848B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Jul 12, 2005·65 cites·3 claims
- 0797US6858602B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Feb 22, 2005·72 cites·9 claims
- 0896US7045541B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted May 16, 2006·63 cites·5 claims
- 0994US7329782B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2002·Granted Feb 12, 2008·34 cites·1 claims
- 1092US7547802B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Jun 16, 2009·10 cites·2 claims
- 1191US7851494B2Method for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Dec 14, 2010·9 cites·6 claims
- 1290US7863475B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Jan 4, 2011·6 cites·1 claims
- 1388US7442796B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Oct 28, 2008·25 cites·4 claims
- 1487US7361686B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Apr 22, 2008·27 cites·5 claims
- 1586US10934284B2Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2019·Granted Mar 2, 2021·2 cites·7 claims
- 1686US7105498B2Acylated uridine and cytidine and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2001·Granted Sep 12, 2006·13 cites·15 claims
- 1785US6465440B2Antimutagenic compositions for treatment and prevention of photodamage to skinWELLSTAT THERAPEUTICS CORP·Filed 2001·Granted Oct 15, 2002·15 cites·30 claims
- 1884US10030015B2Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2014·Granted Jul 24, 2018·3 cites·17 claims
- 1984US9115072B2Compounds and method for reducing uric acidWELLSTAT THERAPEUTICS CORP·Filed 2013·Granted Aug 25, 2015·3 cites·14 claims
- 2084US7582619B2Compositions and methods for treatment of mitochondrial diseasesWELLSTAT THERAPEUTICS CORP·Filed 2006·Granted Sep 1, 2009·4 cites·4 claims
- 2183US7514555B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Apr 7, 2009·16 cites·22 claims
- 2282US9133073B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2013·Granted Sep 15, 2015·2 cites·5 claims
- 2382US8044243B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Oct 25, 2011·5 cites·10 claims
- 2481US7947735B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted May 24, 2011·4 cites·9 claims
- 2581US7915429B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Mar 29, 2011·4 cites·8 claims
- 2680US7973052B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2009·Granted Jul 5, 2011·3 cites·6 claims
- 2780US7709459B2Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitisWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted May 4, 2010·13 cites·2 claims
- 2880US7615575B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Nov 10, 2009·10 cites·8 claims
- 2979US7820721B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted Oct 26, 2010·3 cites·7 claims
- 3079US7115267B2Stimulator of stem cell divisionWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Oct 3, 2006·9 cites·8 claims
- 3178US7935689B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Granted May 3, 2011·3 cites·15 claims
- 3277US7749990B2Compositions for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2008·Granted Jul 6, 2010·2 cites·8 claims
- 3375US8022249B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2006·Granted Sep 20, 2011·2 cites·23 claims
- 3475US6858583B2Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferationWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Feb 22, 2005·2 cites·1 claims
- 3574US6743782B1Acyl deoxyribonucleoside derivatives and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2000·Granted Jun 1, 2004·3 cites·8 claims
- 3673US7169765B1Acyl deoxyribonucleoside derivatives and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2000·Granted Jan 30, 2007·3 cites·8 claims
- 3772US7645772B2Treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2003·Granted Jan 12, 2010·6 cites·7 claims
- 3872US6610654B2Inhibitor of stem cell proliferation and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2002·Granted Aug 26, 2003·1 cites·1 claims
- 3968US8889724B2Tetrazole compounds for reducing uric acidWELLSTAT THERAPEUTICS CORP·Filed 2013·Granted Nov 18, 2014·1 cites·16 claims
- 4068US7906675B2Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Mar 15, 2011·3 cites·3 claims
- 4168US2010041147A1Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferationWELLSTAT THERAPEUTICS CORP·Filed 2009·Application pending·0 cites
- 4268US2022273688A1Treatment of Glycosylation Deficiency DiseasesWELLSTAT THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 4367US2008015209A1Compounds for the treatment of metabolic disordersWELLSTAT THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 4465USRE39573EAntimutagenic compositions for treatment and prevention of photodamage to skinWELLSTAT THERAPEUTICS CORP·Filed 2004·Granted Apr 17, 2007·1 cites·8 claims
- 4565US2005043218A1Inhibitor of stem cell proliferation and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2004·Application pending·0 cites
- 4659US10085957B2Benzoic acid compounds for reducing uric acidWELLSTAT THERAPEUTICS CORP·Filed 2016·Granted Oct 2, 2018·0 cites·10 claims
- 4759US7807654B2Compositions and methods for treatment of mitochondrial diseasesWELLSTAT THERAPEUTICS CORP·Filed 2001·Granted Oct 5, 2010·1 cites·36 claims
- 4859US2018298000A1Aminoquinoline compounds having anticancer activityWELLSTAT THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 4958US2005203066A1Compositions and methods for treatment of mitochondrial diseasesWELLSTAT THERAPEUTICS CORP·Filed 2005·Application pending·0 cites
- 5058US2006166863A1Inhibitor and stimulator of stem cell proliferation and uses thereofWELLSTAT THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →